Welcome to our dedicated page for Strata Critical Medical news (Ticker: SRTA), a resource for investors and traders seeking the latest updates and insights on Strata Critical Medical stock.
News about Strata Critical Medical, Inc. (Nasdaq: SRTA) focuses on its role in time-critical logistics and medical services for the U.S. healthcare and organ transplant industries. Company announcements highlight developments in its organ transport network, integrated organ recovery platform and specialized clinical services delivered through brands such as Trinity Medical Solutions and Keystone Perfusion.
Investors following SRTA news can expect updates on topics the company emphasizes in its communications, including acquisition activity, integration milestones and strategic shifts such as the divestiture of its Passenger business and rebranding from Blade Air Mobility to Strata Critical Medical. Press releases also cover events like Investor Day presentations at the Nasdaq MarketSite and conference appearances, where management discusses its financial framework and business strategy.
Operational news often addresses performance in air and ground logistics for organ transport, growth in organ placement services and expansion of normothermic regional perfusion and perfusion staffing offerings. The company’s updates may also describe how acquisitions like Keystone Perfusion contribute to creating a full-service organ transplant and cardiovascular care platform, as well as efforts to broaden services into other medical sectors.
For readers tracking SRTA, this news stream offers insight into how Strata is shaping its organ logistics and medical services platform, how it characterizes its market position and risk factors, and how management presents its non-GAAP metrics and financial outlook. Regularly reviewing these items can help observers understand the company’s evolving focus on transplant logistics, clinical services and acquisition-led growth within the U.S. healthcare ecosystem.
Strata Critical Medical (Nasdaq: SRTA) reported Q4 2025 revenue of $66.8 million, up 83.5% year-over-year, and full-year 2025 revenue of $197.1 million. GAAP net loss from continuing operations for FY2025 was $20.1 million. Adjusted EBITDA for FY2025 was $14.1 million, above guidance. The company raised 2026 guidance to $260–$275 million revenue and $29–$33 million Adjusted EBITDA, ended FY2025 with $61.2 million cash, and closed a $30 million undrawn asset-backed facility.
Strata Critical Medical (Nasdaq: SRTA) will release fourth-quarter 2025 financial results on March 3, 2026 before the market opens and will host a conference call at 8:00 am Eastern Time the same day.
The call will be hosted by Will Heyburn (Co-CEO and CFO) and Melissa Tomkiel (Co-CEO and General Counsel), include a Q&A session, and require registration to receive dial-in details and a unique PIN. An audio-only webcast will be available on the company investor relations site and a replay will remain available for one year.
Strata (Nasdaq: SRTA) entered a secured, asset-based revolving credit agreement with JPMorgan Chase for up to $30.0 million, with an accordion to $50.0 million subject to conditions. The ABL Facility was undrawn at closing and will support future acquisitions. Owned aircraft are excluded from the collateral package and remain unencumbered, preserving financing optionality. Company executives said the facility improves capital efficiency and enables continued tuck-in acquisition execution in the clinical perfusion and organ transplant logistics space.
Strata Critical Medical (NASDAQ:SRTA) appointed Will Cook to its Board of Directors, effective December 3, 2025. Mr. Cook also joins the Compensation and Nominating and Corporate Governance Committees. He currently serves as President and CEO of Vail Health and previously led University of Colorado Hospital and held senior roles at UPMC and Johns Hopkins Health System. Strata said Cook’s healthcare leadership and industry relationships will support scaling its end-to-end organ recovery and logistics platform and advancing its mission to increase organs available for transplant.
Mr. Cook holds a master’s in health administration from Washington University School of Medicine and a BA in business administration from Texas A&M University.
Strata Critical Medical (Nasdaq: SRTA) held its 2025 Investor Day on Nov 17, 2025, and issued 2026 guidance plus a 2027–2029 medium-term framework.
Key targets: 2026 revenue $255–270M, 2026 Adjusted EBITDA $28–32M, and 2026 free cash flow $15–22M (before aircraft and engine acquisitions).
Medium-term goals include a high‑teens organic Adjusted EBITDA CAGR leading to a doubling of Adjusted EBITDA by 2029, an Adjusted EBITDA margin ~13.0% by 2029, 60–70% free cash flow conversion, and ~$200M of cash available for deployment through 2029.
Strata Critical Medical (Nasdaq: SRTA) reported Q3 2025 revenue of $49.3M, up 36.7% YoY (29.0% excl. the Keystone acquisition). Gross margin improved to 19.4%. Net loss from continuing operations widened to $(9.7)M versus $(5.6)M a year ago. Medical Segment Adjusted EBITDA rose 93.5% to $7.6M, with margin at 15.3%. Flight Profit increased 54.7% to $11.6M and Flight Margin improved to 23.6%. The company closed the Keystone acquisition and divested its Passenger business, ended Q3 with $75.9M in cash and short-term investments, and raised 2025 revenue guidance to $185–195M while reaffirming Adjusted EBITDA guidance of $13–14M. An Investor Day is scheduled for Nov 17, 2025.
Strata Critical Medical (Nasdaq: SRTA) will release third quarter financial results for the period ended September 30, 2025 on Monday, November 10, 2025 before market open and will host a conference call the same day at 8:00 AM Eastern Time.
The call will be led by Co-CEOs Melissa Tomkiel and Will Heyburn and will include a Q&A. Participants must register to receive dial-in details and a unique PIN. An audio-only webcast will be available via the company’s Investors site and a replay will be available for one year.
Business description: Strata provides time-critical air and ground logistics, surgical organ recovery, organ placement, normothermic regional perfusion, and perfusion staffing and equipment solutions under the Trinity Medical Solutions and Keystone Perfusion brands.
Strata Critical Medical (NASDAQ:SRTA), formerly Blade Air Mobility (NASDAQ:BLDE), has announced its upcoming Investor Day scheduled for November 17th, 2025 at the Nasdaq MarketSite in New York City. The event will commence at 2:00 PM ET and will feature presentations from the company's management team.
Interested investors and analysts can register for the event through Strata's Investor Relations website. A live video webcast and presentation materials will be accessible at ir.stratacrtical.com on the day of the event.
Strata Critical Medical (NASDAQ:SRTA) has completed the acquisition of Keystone Perfusion Services LLC for $124 million, representing a 9x multiple of 2025 estimated Adjusted EBITDA. The acquisition combines Strata's existing capabilities with Keystone's expertise in organ recovery and normothermic regional perfusion services.
Keystone is projected to generate $65 million in revenue and $13 million in Adjusted EBITDA for 2025, with revenue growth exceeding 50% compared to 2024. The deal structure includes 88% cash and 12% stock consideration, with potential earn-outs of up to $23 million based on performance through 2028.
Following the acquisition, Strata has updated its 2025 guidance to $180-190 million in revenue and $13-14 million in Adjusted EBITDA. If the acquisition had closed on January 1, 2025, the projected figures would be $225-235 million in revenue and $22-24 million in Adjusted EBITDA.
Strata Critical Medical (NASDAQ:SRTA), previously Blade Air Mobility (NASDAQ:BLDE), has announced its participation in the upcoming 2025 Jefferies Industrials Conference. The company's Co-CEO and CFO, Will Heyburn, will deliver a presentation on September 4, 2025, at 11:30 AM ET.
Investors can access the presentation via webcast, with a replay available afterward on the company's investor relations website at ir.stratacritical.com/news-events.